Straits Research has published its latest report on the Biopharmaceutical Excipients Market, highlighting significant growth projections for the industry. According to the report, the global biopharmaceutical excipients market was valued at USD 2.13 billion in 2022. It is estimated to reach USD 3.75 million by 2031, growing at a CAGR of 7.76% during the forecast period (2023–2031).
Defination:
Biopharma excipients is often added to formulations and dosage forms to stabilize proteins and optimize other desirable properties. Aside from considerations of the excipients' safety, toxicity, and immunogenicity, the choice of excipients in pharma is needed to be guided by the knowledge of degradation pathways of active pharmaceutical ingredients and mechanisms by which different excipients ameliorate those instabilities.
Download Free Request Sample Report @ https://straitsresearch.com/report/biopharmaceutical-excipients-market/request-sample
Market Key Trends
The Biopharmaceutical Excipients Market is experiencing rapid expansion due to the increasing demand for biologic drugs and advancements in drug formulation technologies. Key trends include:
Rising Adoption of Biologics – The growing prevalence of chronic diseases such as cancer, autoimmune disorders, and infectious diseases is driving the demand for biopharmaceutical excipients.
Innovation in Drug Delivery Systems – New formulation techniques are enhancing drug stability and efficacy, leading to increased investments in excipient research.
Regulatory Approvals and Compliance – Regulatory bodies such as the FDA and EMA are playing a crucial role in defining the standards for biopharmaceutical excipients, fostering market growth.
Sustainability Initiatives – Manufacturers are focusing on the development of eco-friendly and biodegradable excipients to align with global sustainability goals.
Driving Factors
Growing Biopharmaceutical Industry – The increasing reliance on monoclonal antibodies, vaccines, and cell & gene therapies is fueling demand.
Expansion of CMOs and CDMOs – Contract manufacturing and development organizations (CMOs/CDMOs) are actively expanding their operations, leading to greater utilization of excipients.
Rising Investment in R&D – Pharmaceutical companies are investing heavily in research and innovation to improve drug formulation and delivery.
Opportunities
Emerging Markets – Rapid industrialization in developing economies presents new opportunities for biopharmaceutical excipient manufacturers.
Advancements in Nanotechnology – The application of nanotechnology in drug delivery systems is driving demand for specialized excipients.
Strategic Collaborations and Partnerships – Leading pharmaceutical companies are partnering with excipient providers to enhance drug formulation capabilities.
Market Segmentation
The Biopharmaceutical Excipients Market is segmented into various categories based on Excipient Type, Biologics, Scale of Operation, and End-User:
By Excipient:
Bulking Agents
Solubilizers and Surfactants
Buffering and Tonicity Agents
Others
By Biologics:
Monoclonal Antibodies
Vaccines
Others
By Scale of Operation:
Commercial
Research
By End-User:
Pharma and Biotech Companies
CMOs and CDMOs
Academic and Research Institutes
Key Players in the Market
The global Biopharmaceutical Excipients Market is highly competitive, with key players focusing on strategic expansion and product innovation. Leading companies include:
BASF SE
Merck KGaA
Avantor Inc.
Ashland Global Holdings Inc.
Roquette Frères
DFE Pharma
Lubrizol Corporation
Kerry Group plc
Croda International Plc
SPI Pharma
Buy Now@ https://straitsresearch.com/buy-now/biopharmaceutical-excipients-market
Conclusion
The Biopharmaceutical Excipients Market is poised for substantial growth, driven by increasing demand for biologic drugs, technological advancements, and expanding research activities. Companies in this sector are focusing on innovation, sustainability, and strategic partnerships to maintain a competitive edge.
About Us:
Straits Research.com is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.
Contact Us
Email: sales@straitsresearch.com
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
Address: 825 3rd Avenue, New York, NY, USA, 10022
